Pancreas is pleased to publish the guidelines of our affiliate society, The North American Neuroendocrine Tumor Society (NANETS).
NANETS had its initial organizational meeting in Portland, Oregon on September 28, 2006 to establish a professional society with the primary purpose to improve neuroendocrine tumor disease management through increased research and educational opportunities. This founding group was comprised of scientists, physicians, and surgeons representing a variety of specialties, all with a particular interest in neuroendocrine tumors (NETs).
This entire group was challenged to not merely summarize other consensus papers but to enhance the already published data and assure the NANETS standards are "distinctive" and applicable to available and approved treatments in North America. Therefore, the main objective for each of the specialty panels was to assess and compare supporting publications and formulate draft position papers for their working subgroup.